Literature DB >> 15799966

COMMD proteins, a novel family of structural and functional homologs of MURR1.

Ezra Burstein1, Jamie E Hoberg, Amanda S Wilkinson, Julie M Rumble, Rebecca A Csomos, Christine M Komarck, Gabriel N Maine, John C Wilkinson, Marty W Mayo, Colin S Duckett.   

Abstract

MURR1 is a multifunctional protein that inhibits nuclear factor kappaB (NF-kappaB), a transcription factor with pleiotropic functions affecting innate and adaptive immunity, apoptosis, cell cycle regulation, and oncogenesis. Here we report the discovery of a new family of proteins with homology to MURR1. These proteins form multimeric complexes and were identified in a biochemical screen for MURR1-associated factors. The family is defined by the presence of a conserved and unique motif termed the COMM (copper metabolism gene MURR1) domain, which functions as an interface for protein-protein interactions. Like MURR1, several of these factors also associate with and inhibit NF-kappaB. The proteins designated as COMMD or COMM domain containing 1-10 are extensively conserved in multicellular eukaryotic organisms and define a novel family of structural and functional homologs of MURR1. The prototype of this family, MURR1/COMMD1, suppresses NF-kappaB not by affecting nuclear translocation or binding of NF-kappaB to cognate motifs; rather, it functions in the nucleus by affecting the association of NF-kappaB with chromatin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799966     DOI: 10.1074/jbc.M501928200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  117 in total

1.  COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.

Authors:  Bart van de Sluis; Xicheng Mao; Yali Zhai; Arjan J Groot; Jeroen F Vermeulen; Elsken van der Wall; Paul J van Diest; Marten H Hofker; Cisca Wijmenga; Leo W Klomp; Kathleen R Cho; Eric R Fearon; Marc Vooijs; Ezra Burstein
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Transducin β-like protein 1 recruits nuclear factor κB to the target gene promoter for transcriptional activation.

Authors:  Sivakumar Ramadoss; Jiong Li; Xiangming Ding; Khalid Al Hezaimi; Cun-Yu Wang
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

3.  COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.

Authors:  Gabriel N Maine; Xicheng Mao; Christine M Komarck; Ezra Burstein
Journal:  EMBO J       Date:  2006-12-21       Impact factor: 11.598

4.  Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.

Authors:  Christopher D Anderson; Gundumi Upadhya; Kendra D Conzen; Jianlou Jia; Elizabeth M Brunt; Venkataswarup Tiriveedhi; Yan Xie; Sabarinathan Ramachandran; Thalachallour Mohanakumar; Nicholas O Davidson; William C Chapman
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

Review 5.  COMMD proteins and the control of the NF kappa B pathway.

Authors:  Gabriel N Maine; Ezra Burstein
Journal:  Cell Cycle       Date:  2007-03-07       Impact factor: 4.534

6.  Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.

Authors:  Prim de Bie; Bart van de Sluis; Ezra Burstein; Peter V E van de Berghe; Patricia Muller; Ruud Berger; Jonathan D Gitlin; Cisca Wijmenga; Leo W J Klomp
Journal:  Gastroenterology       Date:  2007-07-25       Impact factor: 22.682

7.  HSCARG regulates NF-kappaB activation by promoting the ubiquitination of RelA or COMMD1.

Authors:  Min Lian; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

8.  Defining diversity, specialization, and gene specificity in transcriptomes through information theory.

Authors:  Octavio Martínez; M Humberto Reyes-Valdés
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

Review 9.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

10.  Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer.

Authors:  Kord M Kober; Laura Dunn; Judy Mastick; Bruce Cooper; Dale Langford; Michelle Melisko; Alan Venook; Lee-May Chen; Fay Wright; Marilyn Hammer; Brian L Schmidt; Jon Levine; Christine Miaskowski; Bradley E Aouizerat
Journal:  Biol Res Nurs       Date:  2016-03-08       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.